Arrowhead Pharmaceuticals Inc (ARWR)

Arrowhead Pharmaceuticals Inc (ARWR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $8.2B; returns 1 day -0.6%, 1 week +3.8%, 1 year +55.3%.

Arrowhead Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on developing a new class of medicines, known as RNA interference (RNAi) therapeutics, to treat intractable diseases by silencing the genes that cause them.

Groups ARWR belongs to

• Biotechnology
• Life Sciences
• Clinical Stage Biopharma
• Biopharmaceutical
• Pharmaceuticals
• Healthcare
• Commercial Stage Biotech
• Metabolic Disorders
• R&D

ARWR financial model: income statement, cash flow and balance sheet